Finance

Beta
Ask
Lists
DSFIR:AMS
DSM-Firmenich AG
€73.80
+3.10%
(+2.22) 1D
Jun 12, 5:35:24 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DSFIR...
Open
€72.12
High
€73.94
Low
€72.12
Mkt. cap
18.60B
Avg. vol.
1.31M
Volume
856.59K
Dividend
3.39%
Quarterly dividend
€0.62
Ex-dividend date
May 11, 2026
P/E ratio
63.79
52-wk high
€97.44
52-wk low
€55.22
EPS
€1.16
No. of employees
27K
Open
€72.12
High
€73.94
Low
€72.12
Mkt. cap
18.60B
Avg. vol.
1.31M
Volume
856.59K
Dividend
3.39%
Quarterly dividend
€0.62
Ex-dividend date
May 11, 2026
P/E ratio
63.79
52-wk high
€97.44
52-wk low
€55.22
EPS
€1.16
No. of employees
27K
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to DSFIR in the past 3 months
Hold
Buy
2
Hold
4
Sell
2
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for DSFIR in the last 3 months.
Highest
Current €73.80
€86.00 (+16.53%)
Average
€70.71 (-4.19%)
Lowest
€60.00 (-18.70%)
News stories
From sources across the web
About DSM-Firmenich AG
CEO-
Employees26.9K
Founded1902
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.26B
3.26B
3.07B
2.94B
Cost of goods sold
2.06B
2.06B
-
-
Cost of revenue
2.06B
2.06B
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
797.00M
797.00M
-
-
Total operating expenses
2.86B
2.86B
-
-
Operating income
393.00M
393.00M
-
-
Other non operating income
-
-
-
-
EBT including unusual items
331.50M
331.50M
-
-
EBT excluding unusual items
331.50M
331.50M
-
-
Income tax expense
61.00M
61.00M
-
-
Effective tax rate
18.40%
18.40%
-
-
Other operating expenses
797.00M
797.00M
-
-
Net income
255.00M
255.00M
-
-
Net profit margin
7.83%
7.83%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-37.00M
-37.00M
-
-
Net interest expenses
-37.00M
-37.00M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
683.00M
683.00M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more